Williams, Lewis T.

Williams, Lewis T.
	Affiliated Entities Aquinox Pharmaceuticals (usa) Inc Arcellx, Inc. Beckman Instruments, Inc. Five Prime Therapeutics, Inc. Protagonist Inc         Protagonist Therapeutics, Inc.

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	3/23/2011	Delaware Court of Chancery	6306-CS	Cox, Richard vs Beckman Coulter Inc et al	Defendant
	9/24/2004	United States Patent and Trademark Office	10948571	Human cDNA clones comprising polynucleotides encoding polype...	Applicant
	7/28/2003	United States Patent and Trademark Office	10629771	Novel human genes and gene expression products	Applicant
	2/15/2002	United States Patent and Trademark Office	10076555	Novel human genes and gene expression products I	Applicant
	5/10/2001	United States Patent and Trademark Office	09854124	Diagnostic and therapeutic methods using molecules different...	Applicant
	3/9/2001	United States Patent and Trademark Office	09803719	Human genes and gene expression products	Applicant
	6/30/2000	United States Patent and Trademark Office	09611527	Novel human genes and gene expression products	Applicant
	9/22/1999	United States Patent and Trademark Office	09400947	Diagnostic And Therapeutic Methods Using Molecules Different...	Applicant
	5/13/1999	United States Patent and Trademark Office	09313292	Novel Human Genes And Gene Expression Products V	Applicant
	3/5/1999	United States Patent and Trademark Office	09263914	Novel Promoter For Vegf Receptor	Applicant
	12/21/1998	United States Patent and Trademark Office	09217471	Novel Human Genes And Gene Expression Products I	Applicant
	10/13/1998	United States Patent and Trademark Office	09170996	Polynucleotides Encoding Phosphatidylinositol 3-kinases	Applicant
	9/25/1996	United States Patent and Trademark Office	08719742	Combination Pdgf, Kgf, Igf, And Igfbp For Wound Healing	Applicant
	2/12/1996	United States Patent and Trademark Office	08609049	Novel Pi 3-kinase Polypeptides	Applicant
	11/9/1995	United States Patent and Trademark Office	08556424	Novel Promoter For Vegf Receptor	Applicant
	11/1/1995	United States Patent and Trademark Office	08551687	Nucleic Acid Encoding Novel Protein Domain Which Binds Tyros...	Applicant
	6/5/1995	United States Patent and Trademark Office	08461917	Human Platelet-derived Growth Factor Receptors	Applicant
	6/5/1995	United States Patent and Trademark Office	08462728	Method For Inhibiting The Activity Of A Platelet-derived Fac...	Applicant
	6/5/1995	United States Patent and Trademark Office	08464436	Platelet-derived Growth Factor Receptors	Applicant
	6/2/1995	United States Patent and Trademark Office	08458938	Receptors For Fibroblast Growth Factors	Applicant
	6/2/1995	United States Patent and Trademark Office	08459082	Assays Using Receptors For Fibroblast Growth Factors	Applicant
	6/2/1995	United States Patent and Trademark Office	08459395	Receptors For Fibroblast Growth Factors	Applicant
	3/20/1995	United States Patent and Trademark Office	08408519	Novel Ras P21-interacting Protein (rgl) And Its Ras Interact...	Applicant
	12/9/1994	United States Patent and Trademark Office	08353550	Assay Employing Novel Protein Domain Which Binds Tyrosine Ph...	Applicant
	4/11/1994	United States Patent and Trademark Office	08226243	Platelet-derived Growth Factor Receptors	Applicant
	2/13/1992	United States Patent and Trademark Office	07834311	Receptors For Fibroblast Growth Factors	Applicant
	1/31/1991	United States Patent and Trademark Office	07650794	Human Platelet-derived Growth Factor Receptors	Applicant
	2/2/1988	United States Patent and Trademark Office	07151414	Human Platelet-derived Growth Factor Receptor	Applicant

28 Rows Total

Outside Counsel (640)

	Last Name	First Name	Middle Name	Firm	Location
		Christian	A.	Hickman Palermo Truong & Becker, LLP
	Abraham	Jeffrey		Novo Nordisk A/S
	Absher	Alton	L.	Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	Agrawal	Christopher		Boston Scientific Corporation
	Albagli	David		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Alcamo	Elizabeth		Bozicevic Field & Francis LLP
	Alemanni	John	C.	Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	Alexander	Cortney	S.	Finnegan, Henderson, Farabow, Garrett & Dunn...	ATLANTA, GA
	Alexander	Lisa		Novartis Vaccines & Diagnostics, Inc.
	Ali	Mayssam	H.	Finnegan, Henderson, Farabow, Garrett & Dunn...	CAMBRIDGE, MA
	Allen	Eben		Kilpatrick Townsend & Stockton, LLP
	Allen	Kenneth	R.	Kilpatrick Townsend & Stockton, LLP	Palo Alto, CA
	Amanat	Houtan		Kilpatrick Townsend & Stockton, LLP
	Annis	David	C.	Kilpatrick Townsend & Stockton, LLP
	Anthony	Peter		Kilpatrick Townsend & Stockton, LLP
	Anzalone	Steven		Digital Equipment Corporation
	Apple	Randolph	Ted	Kilpatrick Townsend & Stockton, LLP
	Arner	Erika		Novo Nordisk A/S
	Artuz	Robert	John	Kilpatrick Townsend & Stockton, LLP
	Auchterlonie	Thomas		Kilpatrick Townsend & Stockton, LLP
	Azar	Gabriel		Novo Nordisk A/S
	Baba	Edward		Dorsey & Whitney, LLP
	BAENZIGER	JUERG			Emeryville, CA
	Bailey	Benjamin		Novo Nordisk A/S
	Bajefsky	Robert	D.	Finnegan, Henderson, Farabow, Garrett & Dunn...
	Baldwin	Randall	K.	Kilpatrick Townsend & Stockton, LLP	Washington, DC
	Balun	Matthew	J.	Kilpatrick Townsend & Stockton, LLP
	Banks	Thomas		Thomas K. Mcbride
	Banta	Travis		Alg Intellectual Property, LLC
	Barek	Elisabeth		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Barker	M		Evenson McKeown Edwards & Lenahan, PLLC
	Barnett	Sarah		Finnegan/KCI
	Barney	James		Novo Nordisk A/S
	Barrish	Mark	D.	Kilpatrick Townsend & Stockton, LLP
	Basarkar	Girish	M.	Kilpatrick Townsend & Stockton, LLP
	Bass	Samuel	C.	Finnegan, Henderson, Farabow, Garrett & Dunn...
	Bastian	Kevin		Kilpatrick Townsend & Stockton, LLP	SAN FRANCISO, CA
	Baur	Amelia		Finnegan, Henderson, Farabow, Garrett & Dunn...
	BAUTISTA	REGINA		Novartis Vaccines & Diagnostics, Inc.	Emeryville, CA
	BAUTISTA	REGINA			Emeryville, CA
	Becker	Stanley		Loeb & Loeb LLP
	Belagodu	Akarsh	P.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Bennett	Jesse		Kilpatrick Townsend & Stockton, LLP
	Benson	Robert		CORP. PAT. DEPT., P.O. BOX 1045
	Bergstrom	James	T.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Berkowitz	Jeffrey		Merck & Company, Inc.
	Bernard	Eugene	J.	Oblon, Spivak, McClelland, Maier & Neustadt,...
	Bertelson	Michael	Allen	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Bessenger	Frank		Jones, Askew & Lunsford
	Bhattacharyya	Arpita		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Bianco	Krista		Novo Nordisk A/S
	Bingham	Douglas		Husch Blackwell LLP
	Blackburn	Jennifer	L.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Blackburn	Robert			New York, NY
	Blake	Vanessa	M.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Bleker	Ronald		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Bond	Jeremy		Novo Nordisk A/S
	Bookoff	Leslie	I.	Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
	Borden	Paula		Dorsey & Whitney, LLP
	Boring	Landin		Kilpatrick Townsend & Stockton, LLP	Seattle, WA
	Bosch	Michele		Novo Nordisk A/S
	Bower	R		Norris, McLaughlin & Marcus, PA
	Bowers	Carl		Kilpatrick Townsend & Stockton, LLP
	Boyd	David	W.	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Boyle	James	John	Finnegan, Henderson, Farabow, Garrett & Dunn...	RESTON, VA
	BOZICEVIC	KARL			Palo Alto, CA
	Breier	Adam		Novo Nordisk A/S
	Brogan	William	J.	Finnegan, Henderson, Farabow, Garrett & Dunn...
	Brown	Kyle		Kilpatrick Townsend & Stockton, LLP
	Brown	Theodore	G.	Kilpatrick Townsend & Stockton, LLP	Palo Alto, CA
	Brunsvold	Brian	Garrett	Finnegan, Henderson, Farabow, Garrett & Dunn...	Washington, DC
	Burgujian	Richard		Konomi Takeshita
	Burgy	Adriana		Novo Nordisk A/S
	Burke.	Elizabeth	M.	Finnegan, Henderson, Farabow, Garrett & Dunn...
	Burns	Robert II		Novo Nordisk A/S
	Burwell	Lawrence		PAUL J. BERMAN
	Bussey	Megan	Elizabeth	Kilpatrick Townsend & Stockton, LLP	Ny 10036,
	Cai	Mangmang		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Calkins	Charles	W.	United States Army Corps of Engineers	FT. BELVOIR, DC
	Campbell	Louis		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Capron	Aaron		Novo Nordisk A/S
	Carpenter	David		Novartis Vaccines & Diagnostics, Inc.
	Carron	Virginia	L.	Atlanta	Atlanta, GA
	Caserza	Steven		ALAN H. MAC PHERSON
	Cassell	Nathan	S.	Kilpatrick Townsend & Stockton, LLP
	Cathey	Charles		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Catmull	Kelvin		Kilpatrick Townsend & Stockton, LLP
	Celli	Rosemarie	L.	Kilpatrick Townsend & Stockton, LLP
	Cepuritis	Talivaldis		Olson & Hierl, Ltd.	Chicago, IL
	Chadeayne	Andrew		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Chakravorty	Meenakshy		Novo Nordisk A/S
	Chandra	Shweta		Bozicevic Field & Francis LLP	EAST PALO ALTO, CA
	Chandran	Biju		Novo Nordisk A/S
	Chang	Hojin		Finnegan, Henderson, Farabow, Garrett & Dunn...
	Chang	James	K.	Rothwell, Figg, Ernst & Manbeck, PC	Washington, DC
	CHANG	KO-FANG		Kilpatrick Townsend & Stockton, LLP
	Chang	Shin	Tsen	Kilpatrick Townsend & Stockton, LLP
	Chapman	Ernest	R.	Finnegan, Henderson, Farabow, Garrett & Dunn...
	CHAPMAN	JENNIFER			East Hanover, NJ
	Charney	Reagan		Finnegan, Henderson, Farabow, Garrett & Dunn...

640 Rows Total	Page 1 of 7 | Go To

Filter By Form All Records 3 4 4/A From To

	Date	Entity	Form Number	Description
	1/6/2025	Protagonist Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	1/4/2024	Protagonist Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	1/18/2023	Protagonist Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	5/27/2022	Protagonist Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	2/9/2022	Arcellx, Inc.	4	Statement of changes in beneficial ownership of securities
	2/3/2022	Arcellx, Inc.	3	Initial statement of beneficial ownership of securities
	5/28/2021		4	Statement of changes in beneficial ownership of securities
	5/13/2021		4	Statement of changes in beneficial ownership of securities
	5/29/2020	Protagonist Inc	4	Statement of changes in beneficial ownership of securities
	5/7/2020	Aquinox Pharmaceuticals (usa) Inc	4	Statement of changes in beneficial ownership of securities
	10/15/2019	Aquinox Pharmaceuticals (usa) Inc	4	Statement of changes in beneficial ownership of securities
	9/4/2019	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	8/12/2019	Aquinox Pharmaceuticals (usa) Inc	3	Initial statement of beneficial ownership of securities
	6/12/2019	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	6/11/2019	Protagonist Inc	4	Statement of changes in beneficial ownership of securities
	2/28/2019	Five Prime Therapeutics, Inc.	4/A
	2/27/2019	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	2/7/2019	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	11/13/2018	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	9/5/2018	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	6/12/2018	Protagonist Inc	4	Statement of changes in beneficial ownership of securities
	2/28/2018	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	2/13/2018	Five Prime Therapeutics, Inc.	4/A
	2/13/2018	Five Prime Therapeutics, Inc.	4/A
	2/7/2018	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	9/6/2017	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	6/15/2017	Protagonist Inc	4	Statement of changes in beneficial ownership of securities
	6/8/2017	Protagonist Inc	3	Initial statement of beneficial ownership of securities
	3/3/2017	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	2/9/2017	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	1/5/2017	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	12/23/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	9/15/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	9/1/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	8/29/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	5/13/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	4/22/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	4/18/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	4/15/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	4/7/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	3/31/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	3/3/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	2/8/2016	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	12/28/2015	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	11/18/2015	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	10/26/2015	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	10/19/2015	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	9/23/2015	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	8/21/2015	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	8/19/2015	Five Prime Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities

72 Rows Total	Page 1 of 2 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	8/24/2023	Walking Fish Therapeutics	Assignee	Application Publication	18314778 20240002793	Modified B Cells And Methods Of Use Thereof Modified B Cells And Methods Of Use Thereof
	7/25/2023	Walking Fish Therapeutics	Assignee	Application Publication Patent	18316198 20240034995 12037604	Modified B Cells And Methods Of Use Thereof Modified B Cells And Methods Of Use Thereof Modified B Cells And Methods Of Use Thereof
	4/26/2022	Walking Fish Therapeutics	Assignee	Application Publication	17465759 20220073876	Modified B Cells And Methods Of Use Thereof Modified B Cells And Methods Of Use Thereof
	12/15/2015	Five Prime Therapeutics, Inc.	Assignee	Application Publication	14773329 20160017024	Fam150a, Fam150b, And Fam150 Antagonists And Uses Thereof Fam150a, Fam150b, And Fam150 Antagonists And Uses Thereof
	1/2/2014	Five Prime Therapeutics, Inc.	Assignee	Application Publication Patent	14048841 20140140995 9192683	Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Methods Of Treating Disease With Fgfr1 Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins
	12/11/2013	Five Prime Therapeutics, Inc.	Assignee	Application Publication	14019684 20140086840	Therapeutic Antibody Target Validation and Screening In Vivo Therapeutic Antibody Target Validation and Screening In Vivo
	11/6/2013	Five Prime Therapeutics, Inc.	Assignee	Application Publication	14048834 20140170145	Compositions And Methods Of Use For Mgd-csf In Disease Treatment Compositions And Methods Of Use For Mgd-csf In Disease Treatment
	8/12/2013	Five Prime Therapeutics, Inc.	Assignee	Application Publication Patent	13905042 20130324701 9173957	Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Fgfr2 Fusion Proteins Comprising C-terminal Deletion Mutants Of Fgfr2-ii... Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins
	8/12/2013	Five Prime Therapeutics, Inc.	Assignee	Application Publication Patent	13227398 20130065276 8580936	Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins POLYNUCLEOTIDES ENCODING FGFR1-lllc ECD FUSION PROTEINS
	11/16/2012	Five Prime Therapeutics, Inc.	Assignee	Application Publication Patent	13446254 20120258071 8575312	Compositions and Methods of Use for MGD-CSF in Disease Treatment Compositions And Methods Of Use For Mgd-csf In Disease Treatment Compositions and Methods of Use for MGD-CSF in Disease Treatment
	2/28/2012	Five Prime Therapeutics, Inc.	Assignee	Application Publication	13378318 20120183477	Therapeutic Antibody Target Validation and Screening In Vivo Therapeutic Antibody Target Validation and Screening In Vivo
	8/30/2011	Five Prime Therapeutics, Inc.	Assignee	Application Publication Patent	12992582 20110288024 8324165	Compositions For Treating Arthritis Comprising Hg1023575 Polypeptide Compositions For Treating Arthritis Comprising Hg1023575 Polypeptide Compositions For Treating Arthritis Comprising Hg1023575 Polypeptide
	1/8/2008	Five Prime Therapeutics, Inc.	Assignee	Application Application Publication Publication Patent Patent	11795915 11795915 20090018061 20090018061 8168588 8168588	Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ...
	1/8/2008	Five Prime Therapeutics, Inc.	Assignee	Application Publication	11442244 20070054851	Methods of and compositions for stimulation of glucose uptake into muscl... Methods of and compositions for stimulation of glucose uptake into muscl...
	1/8/2008	Five Prime Therapeutics, Inc.	Assignee	Application Application Publication Publication	11632319 11632319 20070264277 20070264277	Compositions and Methods of Use for Mgd-Csf in Disease Treatment Compositions and Methods of Use for Mgd-Csf in Disease Treatment Compositions and Methods of Use for Mgd-Csf in Disease Treatment Compositions and Methods of Use for Mgd-Csf in Disease Treatment
	1/8/2008	Five Prime Therapeutics, Inc.	Assignee	Application Application Publication Patent Patent	11587651 11587651 20100062009 7776564 7776564	Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ...
	5/30/2007	Five Prime Therapeutics, Inc.	Assignee	Application Publication Patent	11791889 20080171689 7678890	Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins
	3/2/2007	Five Prime Therapeutics, Inc.	Assignee	Application Publication Patent	11791889 20080171689 7678890	Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins
	3/2/2007	Five Prime Therapeutics, Inc.	Assignee	Application Publication	10583146 20070248605	Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeut... Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeut...
	2/2/2007	Five Prime Therapeutics, Inc.	Assignee	Application Publication	10591451 20070258949	Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and M... Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and M...
	1/18/2007	Chiron Corporation	Assignee	Application Publication	11654824 20070128710	Novel protein associated with cell stress response Novel protein associated with cell stress response
	9/28/2006	Novartis Vaccines And Diagnostics, Inc.	Assignee	Application Publication Patent	10644548 20040137569 7279554	Notch Receptor Ligands And Uses Thereof Notch Receptor Ligands And Uses Thereof Notch Receptor Ligands And Uses Thereof
	8/15/2006	The Regents Of The University Of Califor...	Assignee	Application Patent	08423646 6280964	Binding Sites For Phosphotyrosine Binding Domains Binding Sites For Phosphotyrosine Binding Domains
	12/19/2005	Chiron Corporation	Assignee	Application Publication	10498033 20060275747	Endogenous retrovirus up-regulated in prostate cancer Endogenous retrovirus up-regulated in prostate cancer
	12/14/2005	Chiron Ocrporation	Assignee	Application Publication	10497786 20070037147	Endogenous retrovirus polypeptides linked to oncogenic transformation Endogenous retrovirus polypeptides linked to oncogenic transformation
	11/3/2005	Five Prime Therapeutics, Inc.	Assignee	Application Publication	11003840 20060035373	Stem cell libraries Stem cell libraries
	6/7/2005	Five Prime Therapeutics, Inc.	Assignee	Application Publication	10516605 20050244970	Stem cell libraries Stem cell libraries
	5/31/2005	The Regents Of The University Of Califor...	Assignee	Application Publication Patent	10464939 20040005688 6958238	Isolated Dishevelled Associated Kinases, Polynucleotides Encoding The Ki... Isolated Dishevelled Associated Kinases, Polynucleotides Encoding The Ki... Isolated Dishevelled Associated Kinases, Polynucleotides Encoding The Ki...
	5/31/2005	Five Prime Therapeutics, Inc.	Assignee	Application Publication	10948571 20060084799	Human cDNA clones comprising polynucleotides encoding polypeptides and m... Human cDNA clones comprising polynucleotides encoding polypeptides and m...
	3/18/2005	Chiron Corporation	Assignee	Application Publication Patent	10779543 20050227917 8101349	Gene Products Differentially Expressed In Cancerous Cells And Their Meth... Gene Products Differentially Expressed In Cancerous Cells And Their Meth... Gene Products Differentially Expressed In Cancerous Cells And Their Meth...
	7/30/2004	Chiron Corporation	Assignee	Application Publication Patent	10016604 20100136522 7776523	Endogenous Retroviruses Up-regulated In Prostate Cancer Endogenous Retroviruses Up-regulated In Prostate Cancer Endogenous Retroviruses Up-regulated In Prostate Cancer
	7/7/2004	Chiron Corporation	Assignee	Application Publication	10076555 20030065156	Novel human genes and gene expression products I Novel human genes and gene expression products I
	7/1/2004	Chiron Corporation	Assignee	Application Publication	10609021 20040086913	Human genes and gene expression products XVI Human genes and gene expression products XVI
	6/29/2004	Chiron Corporation	Assignee	Application Publication	09854124 20020076735	Diagnostic and therapeutic methods using molecules differentially expres... Diagnostic and therapeutic methods using molecules differentially expres...
	3/29/2004	Chiron Corporation	Assignee	Application Publication	10601610 20040091898	PI 3-kinase fusion mutants and uses thereof PI 3-kinase fusion mutants and uses thereof
	5/1/2002	Chiron Corporation	Assignee	Application Publication	09803719 20030044783	Human genes and gene expression products Human genes and gene expression products
	4/16/2001	Chiron Corporation	Assignee	Application Patent	09641612 6703221	Notch Receptor Ligands And Uses Thereof Notch Receptor Ligands And Uses Thereof
	4/13/2001	Chiron Corporation	Assignee	Application Patent	09641612 6703221	Notch Receptor Ligands And Uses Thereof Notch Receptor Ligands And Uses Thereof
	8/14/2000	Chiron Corporation	Assignee	Application Patent	09544776 7186530	Novel Protein Associated With Cell Stress Response Novel Protein Associated With Cell Stress Response
	5/11/2000	Chiron Corporation	Assignee	Application Patent	09472112 6512102	Compositions And Methods Of Diagnosis And Treatment Using Casein Kinase ... Compositions And Methods Of Diagnosis And Treatment Using Casein Kinase ...
	1/10/2000	Chiron Corporation	Assignee	Application Patent	09297648 6964868	Human Genes And Gene Expression Products Ii Human Genes And Gene Expression Products Ii
	10/18/1999	Chiron Corporation	Assignee	Application Patent	09313292 7122373	Novel Human Genes And Gene Expression Products V Novel Human Genes And Gene Expression Products V
	2/18/1999	Chiron Corporation	Assignee	Application Patent	09206344 6432668	Polynucleotides Encoding Human Cyclin-dependent Kinase (hpftaire) Polynucleotides Encoding Human Cyclin-dependent Kinase (hpftaire)
	2/1/1999	Chiron Corporation	Assignee	Application Patent	09195868 6090621	Signaling Inositol Polyphosphate 5-phosphatases (sips) Signaling Inositol Polyphosphate 5-phosphatases (sips)
	4/28/1998	Regents Of The University Of California	Assignee	Application Patent	08982493 6110695	Modulating The Interaction Of The Chemokine, B Lymphocyte Chemoattractan... Modulating The Interaction Of The Chemokine, B Lymphocyte Chemoattractan...
	10/17/1997	Chiron Corporation	Assignee	Application Patent	08861745 6165733	Gamma Ii Adaptin Gamma Ii Adaptin
	7/14/1997	Chiron Corporation	Assignee	Application Patent	08832571 6613956	Pi-3-kinase Fusion Mutants And Uses Thereof Pi-3-kinase Fusion Mutants And Uses Thereof
	2/28/1997	Regents Of The University Of California	Assignee	Application Patent	08751512 6001962	Modified Fas Ligands Modified Fas Ligands
	6/17/1996	Regents Of The University Of California	Assignee	Application Patent	08609049 5948664	Novel Pi 3-kinase Polypeptides Novel Pi 3-kinase Polypeptides
	3/25/1996	Regents Of The University Of California	Assignee	Application Patent	08560005 6001354	Novel Grb2 Associating Polypeptides And Nucleic Acids Encoding Therefor Novel Grb2 Associating Polypeptides And Nucleic Acids Encoding Therefor

50 Rows Total

Williams, Lewis T. has not been involved in any trademark assignment transactions in the PlainSite database.

Affiliated Entities

• Aquinox Pharmaceuticals (usa) Inc
• Arcellx, Inc.
• Beckman Instruments, Inc.
• Five Prime Therapeutics, Inc.
• Protagonist Inc
• Protagonist Therapeutics, Inc.

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.